183 related articles for article (PubMed ID: 19760196)
61. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?
Konstantinidis IT; Warshaw AL; Allen JN; Blaszkowsky LS; Castillo CF; Deshpande V; Hong TS; Kwak EL; Lauwers GY; Ryan DP; Wargo JA; Lillemoe KD; Ferrone CR
Ann Surg; 2013 Apr; 257(4):731-6. PubMed ID: 22968073
[TBL] [Abstract][Full Text] [Related]
62. Malignant gastrointestinal stromal tumors of the small intestine: a review of 50 cases from a prospective database.
Crosby JA; Catton CN; Davis A; Couture J; O'Sullivan B; Kandel R; Swallow CJ
Ann Surg Oncol; 2001; 8(1):50-9. PubMed ID: 11206225
[TBL] [Abstract][Full Text] [Related]
63. Addition of Bevacizumab to First-Line Palliative Chemotherapy in Patients with Metastatic Small Bowel Adenocarcinoma: A Population-Based Study.
Legué LM; van Erning FN; Bernards N; Lemmens VEPP; de Hingh IHJT; Creemers GJ
Target Oncol; 2019 Dec; 14(6):699-705. PubMed ID: 31625001
[TBL] [Abstract][Full Text] [Related]
64. Small intestinal adenocarcinoma: rarely considered, often missed?
Neely D; Ong J; Patterson J; Kirkpatrick D; Skelly R
Postgrad Med J; 2013 Apr; 89(1050):197-201. PubMed ID: 23412393
[TBL] [Abstract][Full Text] [Related]
65. Molecular profiling and identification of prognostic factors in Chinese patients with small bowel adenocarcinoma.
Pan H; Cheng H; Wang H; Ge W; Yuan M; Jiang S; Wan X; Dong Y; Liu Z; Zhao R; Fang Y; Lou F; Cao S; Han W
Cancer Sci; 2021 Nov; 112(11):4758-4771. PubMed ID: 34449929
[TBL] [Abstract][Full Text] [Related]
66. Pancreatic Cancer Surgery: The New R-status Counts.
Strobel O; Hank T; Hinz U; Bergmann F; Schneider L; Springfeld C; Jäger D; Schirmacher P; Hackert T; Büchler MW
Ann Surg; 2017 Mar; 265(3):565-573. PubMed ID: 27918310
[TBL] [Abstract][Full Text] [Related]
67. The American College of Surgeons Commission on Cancer and the American Cancer Society. Adenocarcinoma of the small bowel: review of the National Cancer Data Base, 1985-1995.
Howe JR; Karnell LH; Menck HR; Scott-Conner C
Cancer; 1999 Dec; 86(12):2693-706. PubMed ID: 10594865
[TBL] [Abstract][Full Text] [Related]
68. Prognostic factors in primary adenocarcinoma of the small intestine: 13-year single institution experience.
Chaiyasate K; Jain AK; Cheung LY; Jacobs MJ; Mittal VK
World J Surg Oncol; 2008 Jan; 6():12. PubMed ID: 18237404
[TBL] [Abstract][Full Text] [Related]
69. Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases From a Small Bowel Adenocarcinoma: Multi-Institutional Experience.
Liu Y; Yonemura Y; Levine EA; Glehen O; Goere D; Elias D; Morris DL; Sugarbaker PH; Tuech JJ; Cashin P; Spiliotis JD; de Hingh I; Ceelen W; Baumgartner JM; Piso P; Katayama K; Deraco M; Kusamura S; Pocard M; Quenet F; Fushita S;
Ann Surg Oncol; 2018 May; 25(5):1184-1192. PubMed ID: 29484565
[TBL] [Abstract][Full Text] [Related]
70. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
[TBL] [Abstract][Full Text] [Related]
71. What to do after R1-resection of adenocarcinomas of the esophagogastric junction?
Gertler R; Richter J; Stecher L; Nitsche U; Feith M
J Surg Oncol; 2016 Sep; 114(4):428-33. PubMed ID: 27333949
[TBL] [Abstract][Full Text] [Related]
72. Palliative chemotherapy for patients with synchronous metastases of small-bowel adenocarcinoma: A reflection of daily practice.
Legué LM; Bernards N; Lemmens VE; de Hingh IH; Creemers GJ; van Erning FN
United European Gastroenterol J; 2019 Dec; 7(10):1380-1388. PubMed ID: 31839964
[TBL] [Abstract][Full Text] [Related]
73. Prognostic value of lymph node evaluation in small bowel adenocarcinoma: analysis of the surveillance, epidemiology, and end results database.
Overman MJ; Hu CY; Wolff RA; Chang GJ
Cancer; 2010 Dec; 116(23):5374-82. PubMed ID: 20715162
[TBL] [Abstract][Full Text] [Related]
74. Retrospective analysis of 119 small bowel adenocarcinoma in Chinese patients.
Guo XC; Mao ZY; Su D; Wang LJ; Zhang TT; Bai L
Cancer Invest; 2014 Jun; 32(5):178-83. PubMed ID: 24654694
[TBL] [Abstract][Full Text] [Related]
75. Management of small bowel adenocarcinoma.
Kummar S; Ciesielski TE; Fogarasi MC
Oncology (Williston Park); 2002 Oct; 16(10):1364-9; discussion 1370, 1372-3. PubMed ID: 12435206
[TBL] [Abstract][Full Text] [Related]
76. Evolving pharmacotherapeutic strategies for small bowel adenocarcinoma.
Trikudanathan G; Dasanu CA
Expert Opin Pharmacother; 2010 Jul; 11(10):1695-704. PubMed ID: 20446863
[TBL] [Abstract][Full Text] [Related]
77. Phase II Study of Panitumumab in RAS Wild-Type Metastatic Adenocarcinoma of Small Bowel or Ampulla of Vater.
Gulhati P; Raghav K; Shroff R; Varadhachary G; Javle M; Qiao W; Wang H; Morris J; Wolff R; Overman MJ
Oncologist; 2018 Mar; 23(3):277-e26. PubMed ID: 29259073
[TBL] [Abstract][Full Text] [Related]
78. Prognostic value of the TNM-classification for small bowel cancer.
Contant CM; Damhuis RA; van Geel AN; van Eijck CH; Wiggers T
Hepatogastroenterology; 1997; 44(14):430-4. PubMed ID: 9164514
[TBL] [Abstract][Full Text] [Related]
79. Abdominoperineal resection for locally recurrent rectal cancer.
Bergamaschi R; Pessaux P; Burtin P; Arnaud JP
Tech Coloproctol; 2001 Aug; 5(2):97-102. PubMed ID: 11862566
[TBL] [Abstract][Full Text] [Related]
80. Primary small intestinal malignant tumors: survival analysis of 48 postoperative patients.
Cao J; Zuo Y; Lv F; Chen Z; Li J
J Clin Gastroenterol; 2008 Feb; 42(2):167-73. PubMed ID: 18209587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
